Tag: biopharmaceuticals
-
Regulus Therapeutics Names VP
San Diego-based Regulus Therapeutics, a biopharmaceuticals firm focused on targeted microRNA, said it has named Mohammad Ahmadian, Ph.D., as Vice President, Chemistry and Pharmaceutical Development. Ahmadian previously was Vice President & Resident Dir…
-
Avidity Biosciences Shuffles Board
La Jolla-based biopharmaceuticals developer Avidity Biosciences has shuffled its board, saying today that it has named Eric Mosbrooker to its board, with Roderick Wong, M.D. departing. Mosbrooker is the chief operations officer for Cognoa. He also has …
-
Immix Biopharma Files For IPO
Los Angeles-based biopharmaceuticals startup Immix Biopharma said it has filed for an IPO, and has submitted a confidential draft registration statement/S-1 with the Securities and Exchange Commission. Details on that IPO have yet to be announced. Immi…
-
Janux Therapeutics Prices IPO, Hits Nasdaq Today
La Jolla-based biopharmaceuticals startup Janux Therapeutics said early this morning that it has priced its IPO, offering up 11,400,000 shares of its common stock at $17.00 per share. The company begins trading this morning on the Nasdaq Global market …
-
Evofem Biosciences Raises $50M In Offering
San Diego-based Evofem Biosciences, a developer of biopharmaceuticals for female reproductive health, reported it raised $50M in its previously announced public offering. It said it will net approximately $46.6M after underwriting discounts, commission…
-
Evofem Prices $50M Offering
San Diego-based Evofem Biosciences, which is developing biopharmaceuticals for women’s contraception and related areas, says it has priced a $50M, public offering, and also will receive up to an additoinal $50M upon exercise of accompanying short-term …